BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 32333919)

  • 1. Bacterial outer membrane vesicles as a platform for biomedical applications: An update.
    Li M; Zhou H; Yang C; Wu Y; Zhou X; Liu H; Wang Y
    J Control Release; 2020 Jul; 323():253-268. PubMed ID: 32333919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outer membrane vesicles (OMVs) enabled bio-applications: A critical review.
    Huang Y; Nieh MP; Chen W; Lei Y
    Biotechnol Bioeng; 2022 Jan; 119(1):34-47. PubMed ID: 34698385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in various bio-applications of bacteria-derived outer membrane vesicles.
    Sadeghi L; Mohit E; Moallemi S; Ahmadi FM; Bolhassani A
    Microb Pathog; 2023 Dec; 185():106440. PubMed ID: 37931826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial outer membrane vesicles in cancer: Biogenesis, pathogenesis, and clinical application.
    Li D; Zhu L; Wang Y; Zhou X; Li Y
    Biomed Pharmacother; 2023 Sep; 165():115120. PubMed ID: 37442066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial Outer Membrane Vesicles as Antibiotic Delivery Vehicles.
    Collins SM; Brown AC
    Front Immunol; 2021; 12():733064. PubMed ID: 34616401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial Outer Membrane Vesicles: From Discovery to Applications.
    Sartorio MG; Pardue EJ; Feldman MF; Haurat MF
    Annu Rev Microbiol; 2021 Oct; 75():609-630. PubMed ID: 34351789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial outer membrane vesicles as potential biological nanomaterials for antibacterial therapy.
    Huang W; Meng L; Chen Y; Dong Z; Peng Q
    Acta Biomater; 2022 Mar; 140():102-115. PubMed ID: 34896632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial outer membrane vesicles as a candidate tumor vaccine platform.
    Wang S; Guo J; Bai Y; Sun C; Wu Y; Liu Z; Liu X; Wang Y; Wang Z; Zhang Y; Hao H
    Front Immunol; 2022; 13():987419. PubMed ID: 36159867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in biomedical applications of bacterial outer membrane vesicles.
    Chen H; Zhou M; Zeng Y; Lv Z; Wang P; Han L
    J Mater Chem B; 2022 Sep; 10(37):7384-7396. PubMed ID: 35792612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OMV Vaccines and the Role of TLR Agonists in Immune Response.
    Mancini F; Rossi O; Necchi F; Micoli F
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial outer membrane vesicle-based cancer nanovaccines.
    Gao X; Feng Q; Wang J; Zhao X
    Cancer Biol Med; 2022 Sep; 19(9):1290-300. PubMed ID: 36172794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
    Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
    Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in outer membrane vesicles of gram-negative bacteria as sub-unit vaccines - A review].
    Yi J; Liu Q; Kong Q
    Wei Sheng Wu Xue Bao; 2016 Jun; 56(6):911-21. PubMed ID: 29727152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens.
    Lei EK; Azmat A; Henry KA; Hussack G
    Appl Microbiol Biotechnol; 2024 Feb; 108(1):232. PubMed ID: 38396192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic profiling of Gram-negative bacterial outer membrane vesicles: Current perspectives.
    Lee J; Kim OY; Gho YS
    Proteomics Clin Appl; 2016 Oct; 10(9-10):897-909. PubMed ID: 27480505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for
    Irene C; Fantappiè L; Caproni E; Zerbini F; Anesi A; Tomasi M; Zanella I; Stupia S; Prete S; Valensin S; König E; Frattini L; Gagliardi A; Isaac SJ; Grandi A; Guella G; Grandi G
    Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21780-21788. PubMed ID: 31591215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A modular vaccine platform enabled by decoration of bacterial outer membrane vesicles with biotinylated antigens.
    Weyant KB; Oloyede A; Pal S; Liao J; Jesus MR; Jaroentomeechai T; Moeller TD; Hoang-Phou S; Gilmore SF; Singh R; Pan DC; Putnam D; Locher C; de la Maza LM; Coleman MA; DeLisa MP
    Nat Commun; 2023 Jan; 14(1):464. PubMed ID: 36709333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial Outer Membrane Vesicles as a Delivery System for Virulence Regulation.
    Yoon H
    J Microbiol Biotechnol; 2016 Aug; 26(8):1343-7. PubMed ID: 27221110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial Outer Membrane Vesicles as a Versatile Tool in Vaccine Research and the Fight against Antimicrobial Resistance.
    Zhu Z; Antenucci F; Villumsen KR; Bojesen AM
    mBio; 2021 Aug; 12(4):e0170721. PubMed ID: 34372691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori Growth Stage Determines the Size, Protein Composition, and Preferential Cargo Packaging of Outer Membrane Vesicles.
    Zavan L; Bitto NJ; Johnston EL; Greening DW; Kaparakis-Liaskos M
    Proteomics; 2019 Jan; 19(1-2):e1800209. PubMed ID: 30488570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.